glp-1 compounders Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market How compounders plan to continue
Description
In a six-month clinical trial, a GLP-1 drug called liraglutide was shown to slow the progression of the disease and improve the cerebral metabolic rate of glucose (CMRglc), which is a measurement of glucose metabolism in the brain important for normal cognitive function
Key topics to discuss include: Your fertility plans and timeline : If you are planning to conceive in the near future, your healthcare provider can advise on the appropriate timing for discontinuing GLP-1 medication
Tsubouchi, S
[DOI] [PMC free article] [PubMed] [Google Scholar] [29].Fitzgerald J
From a treatment point of view, there are clear differences
